Clinical Trials Logo

Ossification, Heterotopic clinical trials

View clinical trials related to Ossification, Heterotopic.

Filter by:

NCT ID: NCT04049461 Not yet recruiting - Cancer of Pancreas Clinical Trials

Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

Start date: September 1, 2019
Phase:
Study type: Observational

To investigate whether pancreatic cancer is the cause of heterotopic ossification of abdominal incision.

NCT ID: NCT03979378 Recruiting - Sodium Thiosulfate Clinical Trials

Treatment of Ectopic Calcification / Ossification With Sodium Thiosulfate (CATSSO)

Start date: February 2015
Phase:
Study type: Observational

Ectopic calcification and ossification complicate many diseases, which are rare for the most part. These calcifications (or ossifications) are generally classified according to their apparent formation mechanism. Even if very different diseases can be at the origin, these calcifications (or ossifications) have as common points: an unknown physiopathology, a composition of calcium pyrophosphate for the most part and l no curative treatment validated to date. Indeed, although several reported cases suggest the potential efficacy of different treatments , none of these treatments is currently recognized as effective because of the absence of confirmation data or because of contradictory results. Sodium thiosulfate (STS) has been used for a long time as an antidote to cyanide poisoning and as a protective agent against cytotoxic side effects such as ifosphamide. More recently, STS has been reported in the treatment of renal calcification. vascular or even subcutaneous. First prospective studies on animal models and in humans seem to confirm the interest of this product in the treatment of these abnormal calcifications. For several months, a magistral preparation in the form of ointment based on STS has been developed by the pharmacy of Limoges University Hospital in order to combine the local effect of STS while avoiding the side effects of an administration of this treatment by systemic way. The first uses of this preparation appear promising and some preliminary results have already been published. The benefit / risk ratio of this approach seems to be advantageous for clinicians since preparations whose composition is close are currently validated by the FDA and the World Health Organisation for the treatment of benign pathologies such as cutaneous dermatophytes or pityriasis versicolor.

NCT ID: NCT03974698 Completed - Clinical trials for Femoral Neck Fractures

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach

Start date: February 1, 2014
Phase: N/A
Study type: Interventional

Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach. Comparing leg length discrepancy, femoral offset, valgus/varus position of the stem. Also is there a difference in heterotopic ossification at 12 months.

NCT ID: NCT03925688 Completed - Clinical trials for Heterotopic Ossification

Assessment of Heterotopic Ossification of Elbow Joint in Relation of Serum Uric Acid.

Start date: March 13, 2019
Phase:
Study type: Observational

Heterotopic ossification (HO) is a common complication after surgical repair of elbow trauma. Uric acid is the end-product of purine metabolism that has any physiological and pathogenic potential functions. However, the relationship of HO and uric acid has not been explored up to now. This study aimed to assess the relationship of HO and uric acid. The investigators retrospectively reviewed the demographics of participants who undergone the surgery for elbow trauma in our hospital between January 2012 and December 2018. One hundred participants included in our study. The participants were divided into two groups by the existing HO or not. The serum uric acid between both groups were compared by using the independent samples student T tests.

NCT ID: NCT03724422 Terminated - Radiation Therapy Clinical Trials

HO Prophylaxis Therapy for Distal Humerus Fractures

Start date: October 9, 2019
Phase: N/A
Study type: Interventional

To determine the effectiveness of 500 cGy dose of radiation therapy vs. an untreated group in the prophylactic treatment of heterotopic ossification in distal humerus fractures

NCT ID: NCT02331628 Completed - Clinical trials for TBI Traumatic Brain Injury

ESWT as a Treatment for Chronic NHO in TBI Patients

Start date: October 2014
Phase: N/A
Study type: Interventional

Effect of Extracorporeal Shock Wave Therapy on Chronic Neurogenic Heterotopic Ossification in Traumatic Brain Injured (TBI) patients Chronic Neurogenic Heterotopic Ossification (NHO) - Heterotopic ossification is a well known late complication of traumatic brain injury. Extracorporeal Shock Wave Therapy - ESWT- is used in various medical situations and is being tested for feasibility of use in TBI patients.

NCT ID: NCT01744314 Recruiting - Clinical trials for Elbow Trauma Requiring Operative Management

Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma

Start date: November 2012
Phase: N/A
Study type: Interventional

Patients who present to our institution with a traumatic injury to their elbow who need operative management will be randomized to one of two groups; a treatment arm and a control arm. The treatment arm will receive a three-week postoperative course of indomethacin while the control group will not. We will follow both groups to assess whether or not indomethacin prophylaxis affects the rate of heterotopic ossification.

NCT ID: NCT01631669 Recruiting - Clinical trials for Ossification, Heterotopic

Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification

Start date: May 2012
Phase: N/A
Study type: Interventional

Hypotheses: H1: Celecoxib, when given less than five days after injury will result in a statistical decrease in the incidence and/or severity of radiographically apparent Heterotopic Ossification when compared to controls. H2a: A biomarker profile will accurately predict which patients in the treatment group will respond to Celecoxib prophylaxis for Heterotopic Ossification. H2b: A biomarker profile will accurately predict which patients in the control group are at highest risk of developing Heterotopic Ossification

NCT ID: NCT01539447 Completed - Clinical trials for Heterotopic Ossification

Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

Start date: January 2012
Phase: Early Phase 1
Study type: Interventional

In a brief summary the study would like to evaluate the effectiveness of Naproxen in preventing radiographically detected heterotopic ossification following hip arthroscopy for the treatment of femoroacetabular impingement.

NCT ID: NCT01022190 Completed - Clinical trials for Ossification, Heterotopic

Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement

Arcoxia
Start date: December 2009
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether Arcoxia is effective in preventing heterotopic ossification after total hip arthroplasty.